[-] Show simple item record

dc.contributor.authorSutovsky, Petereng
dc.contributor.corporatenameUniversity of Missouri (System)eng
dc.contributor.meetingnameMissouri Life Sciences Summit (2010: University of Missouri--Kansas City)eng
dc.date.issued2010-03eng
dc.descriptionScientifically Led National Enterprises Paneleng
dc.description.abstractEach year, US infertility clinics treat 135,000 couples who fail to conceive naturally. Up to 40% of these infertility cases can be attributed to male infertility stemming from poor sperm quality. An additional 20% of couples present at the clinic with idiopathic, unexplained infertility, some of which is in fact hidden, misdiagnosed male infertility. Due to a paucity of accurate diagnostic methods and efficient treatments, the success rate of assisted fertilization, measured by live births, stagnates around the disappointing 35% margin. Many parallels exist between human male infertility and male reproductive performance in farm animals, where the estimated losses from inferior reproductive performance amount to millions of dollars annually, according to USDA.eng
dc.identifier.urihttp://hdl.handle.net/10355/6800eng
dc.languageEnglisheng
dc.relation.ispartofcollectionPresentations (Missouri Regional Life Sciences Summit 2010)eng
dc.relation.ispartofcommunityUniversity of Missouri System. Missouri Summits. Missouri Regional Life Sciences Summit 2010.eng
dc.subjectinfertilityeng
dc.subjectbiomarkerseng
dc.subjectanimal-human parallelseng
dc.subject.disciplineAnimal scienceseng
dc.subject.lcshInfertility, Maleeng
dc.subject.lcshBiochemical markerseng
dc.titleCommercialization of novel biomarkers of male fertility in humans and farm animalseng
dc.typePresentationeng


Files in this item

[PDF]
Thumbnail

This item appears in the following Collection(s)

[-] Show simple item record